Arkema grants an Exclusive Technology License to SEQENS to manufacture PEKK for sale in Long Term Medical Implantable Applications*.

SEQENS, an integrated global player in solutions and ingredients for the pharmaceutical and specialty market, is excited to announce a new step in its collaboration with Arkema, a world leader in specialty materials, with the signature of an exclusive technology license for the manufacturing of PEKK for sale in long term implantable applications.